{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-078612","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2024-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.522327+00:00","generated_at":"2026-06-01T01:18:13.041972+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Aspira Women's Health CFO Torsten Hombeck terminated for cause; CEO interim CFO","bullets":["Dr. Torsten Hombeck terminated as CFO on June 27, 2024 due to personal civil matter unrelated to Company.","Termination deemed 'for cause' under employment agreement; no further payments beyond June 28, 2024 salary.","CEO Nicole Sandford assumes CFO duties on interim basis; search for permanent replacement underway.","Separate June 5, 2024 amendment had raised Hombeck's base salary to $375,000 and added Corporate Secretary title."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-078612","json":"https://secwatch.observer/filing/0000950170-24-078612.json","markdown":"https://secwatch.observer/filing/0000950170-24-078612.md","text":"https://secwatch.observer/filing/0000950170-24-078612.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000095017024078612/0000950170-24-078612-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000095017024078612/awh-20240627.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T01:18:13.041972+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6ff4765be1","claim":"Nicole Sandford was appointed as Chief Financial Officer (interim) at Aspira Women's Health Inc..","evidence_excerpt":"As of June 27, 2024, Nicole Sandford, the Company’s Chief Executive Officer, has taken over Dr. Hombeck’ s duties on an interim basis until a search for his replacement is completed.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024078612/0000950170-24-078612-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed interim CFO"},{"label":"Role","value":"Chief Financial Officer (interim)"}]},{"claim_id":"9287331847","claim":"Torsten Hombeck departed as Chief Financial Officer at Aspira Women's Health Inc..","evidence_excerpt":"On June 27, 2024, the Compensation Committee (the “Committee”) of Aspira Women’s Health Inc. (the “Company”) determined that a personal civil matter interfered with Dr. Torsten Hombeck’ s ability to continue to serve as the Company’s Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024078612/0000950170-24-078612-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated for cause"},{"label":"Role","value":"Chief Financial Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}